These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Verrijken A, Beckers S, Francque S, Hilden H, Caron S, Zegers D, Ruppert M, Hubens G, Van Marck E, Michielsen P, Staels B, Taskinen MR, Van Hul W, Van Gaal L. Obesity (Silver Spring); 2013 Oct 16; 21(10):2138-45. PubMed ID: 23512881 [Abstract] [Full Text] [Related]
7. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage. Donati B, Motta BM, Pingitore P, Meroni M, Pietrelli A, Alisi A, Petta S, Xing C, Dongiovanni P, del Menico B, Rametta R, Mancina RM, Badiali S, Fracanzani AL, Craxì A, Fargion S, Nobili V, Romeo S, Valenti L. Hepatology; 2016 Mar 16; 63(3):787-98. PubMed ID: 26605757 [Abstract] [Full Text] [Related]
8. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. J Clin Endocrinol Metab; 2012 Dec 16; 97(12):4717-23. PubMed ID: 23066121 [Abstract] [Full Text] [Related]
9. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. Zampino R, Coppola N, Cirillo G, Boemio A, Pisaturo M, Marrone A, Macera M, Sagnelli E, Perrone L, Adinolfi LE, Miraglia del Giudice E. J Viral Hepat; 2013 Aug 16; 20(8):517-23. PubMed ID: 23808989 [Abstract] [Full Text] [Related]
10. Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant. Mancina RM, Matikainen N, Maglio C, Söderlund S, Lundbom N, Hakkarainen A, Rametta R, Mozzi E, Fargion S, Valenti L, Romeo S, Taskinen MR, Borén J. J Clin Endocrinol Metab; 2015 May 16; 100(5):E821-5. PubMed ID: 25763607 [Abstract] [Full Text] [Related]
11. Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation. Franko A, Merkel D, Kovarova M, Hoene M, Jaghutriz BA, Heni M, Königsrainer A, Papan C, Lehr S, Häring HU, Peter A. Nutrients; 2018 Sep 17; 10(9):. PubMed ID: 30227635 [Abstract] [Full Text] [Related]
12. The Genetic Variant I148M in PNPLA3 Is Associated With Increased Hepatic Retinyl-Palmitate Storage in Humans. Kovarova M, Königsrainer I, Königsrainer A, Machicao F, Häring HU, Schleicher E, Peter A. J Clin Endocrinol Metab; 2015 Dec 17; 100(12):E1568-74. PubMed ID: 26439088 [Abstract] [Full Text] [Related]
13. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis. Chen LZ, Xin YN, Geng N, Jiang M, Zhang DD, Xuan SY. World J Gastroenterol; 2015 Jan 21; 21(3):794-802. PubMed ID: 25624712 [Abstract] [Full Text] [Related]
14. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery. Krawczyk M, Jiménez-Agüero R, Alustiza JM, Emparanza JI, Perugorria MJ, Bujanda L, Lammert F, Banales JM. Surg Obes Relat Dis; 2016 Dec 21; 12(10):1838-1846. PubMed ID: 27576208 [Abstract] [Full Text] [Related]
15. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. Valenti L, Nobili V, Al-Serri A, Rametta R, Leathart JB, Zappa MA, Dongiovanni P, Fracanzani AL, Alterio A, Roviaro G, Daly AK, Fargion S, Day CP. J Hepatol; 2011 Dec 21; 55(6):1409-14. PubMed ID: 21777557 [Abstract] [Full Text] [Related]
16. PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes. Karamfilova V, Gateva A, Assyov Y, Alexiev A, Savov A, Yaneva N, Ivanova I, Ivanova-Boyanova R, Ivanova R, Vlahova Z, Mateva L, Kamenov Z. J Gastrointestin Liver Dis; 2019 Dec 09; 28(4):433-438. PubMed ID: 31826069 [Abstract] [Full Text] [Related]
17. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S. Hepatology; 2011 Mar 09; 53(3):791-9. PubMed ID: 21319195 [Abstract] [Full Text] [Related]
18. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V. Hepatology; 2010 Oct 09; 52(4):1274-80. PubMed ID: 20648474 [Abstract] [Full Text] [Related]
19. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP. Hepatology; 2010 Apr 09; 51(4):1209-17. PubMed ID: 20373368 [Abstract] [Full Text] [Related]
20. Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B. Zampino R, Coppola N, Cirillo G, Boemio A, Grandone A, Stanzione M, Capoluongo N, Marrone A, Macera M, Sagnelli E, Adinolfi LE, del Giudice EM. Dig Dis Sci; 2015 Oct 09; 60(10):3005-10. PubMed ID: 25986529 [Abstract] [Full Text] [Related] Page: [Next] [New Search]